Approved labelTeriparatide injection prescribing information for approved osteoporosis indications
PopulationWomen and men covered by the approved teriparatide indications
Dose20 mcg
RouteSubcutaneous injection into the thigh or abdomen
FrequencyOnce daily
DurationUse beyond 2 years during a lifetime is considered only when the patient remains at or returns to high fracture risk
PreparationReady-to-use 560 mcg/2.24 mL solution in a prefilled pen intended to deliver twenty-eight 20 mcg doses; no reconstitution. Discard the pen 28 days after first use.